Recombinant Human Papillomavirus 11-valent Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A recombinant, 11-valent, human papillomavirus (HPV) vaccine, produced in Hansenula polymorpha, with potential immunoprotective and antineoplastic properties. Upon administration, recombinant HPV 11-valent vaccine may generate humoral and cellular immunity against the 11 undisclosed types of HPV antigens, thereby preventing cervical infection upon exposure to these 11 types of HPV. In addition, this agent may stimulate an antitumoral cellular immune response against cervical cancer associated with HPV infection.

**Synonyms:** - 11-valent Recombinant HPV Vaccine - 11-valent Recombinant Human Papillomavirus Vaccine - 11-valent Recombinant Human Papillomavirus Vaccine (Hansenula polymorpha)